| Androgen receptor gene aberrations in circulating cell-free DNA: biomarkers of therapeutic resistance in castration-resistant prostate cancer AA Azad, SV Volik, AW Wyatt, A Haegert, S Le Bihan, RH Bell, ... Clinical cancer research 21 (10), 2315-2324, 2015 | 512 | 2015 |
| High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development D Lin, AW Wyatt, H Xue, Y Wang, X Dong, A Haegert, R Wu, S Brahmbhatt, ... Cancer research 74 (4), 1272-1283, 2014 | 395 | 2014 |
| Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract M Sharma, SA Anderson, R Schoop, JB Hudson Antiviral research 83 (2), 165-170, 2009 | 221 | 2009 |
| From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer AV Lapuk, C Wu, AW Wyatt, A McPherson, BJ McConeghy, S Brahmbhatt, ... The Journal of pathology 227 (3), 286-297, 2012 | 213 | 2012 |
| Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapy B Kiss, AW Wyatt, J Douglas, V Skuginna, F Mo, S Anderson, D Rotzer, ... Scientific reports 7 (1), 42713, 2017 | 105 | 2017 |
| BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma R Shrestha, N Nabavi, YY Lin, F Mo, S Anderson, S Volik, HH Adomat, ... Genome medicine 11, 1-12, 2019 | 102 | 2019 |
| p300/CBP-associated factor selectively regulates the extinction of conditioned fear W Wei, CM Coelho, X Li, R Marek, S Yan, S Anderson, D Meyers, ... Journal of Neuroscience 32 (35), 11930-11941, 2012 | 102 | 2012 |
| Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer AW Wyatt, F Mo, K Wang, B McConeghy, S Brahmbhatt, L Jong, ... Genome biology 15, 1-14, 2014 | 94 | 2014 |
| Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer C Wu, AW Wyatt, AV Lapuk, A McPherson, BJ McConeghy, RH Bell, ... The Journal of pathology 227 (1), 53-61, 2012 | 81 | 2012 |
| Stromal gene expression is predictive for metastatic primary prostate cancer F Mo, D Lin, M Takhar, VR Ramnarine, X Dong, RH Bell, SV Volik, ... European urology 73 (4), 524-532, 2018 | 73 | 2018 |
| Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target CC Collins, SV Volik, AV Lapuk, Y Wang, PW Gout, C Wu, H Xue, ... Molecular cancer therapeutics 11 (3), 775-783, 2012 | 52 | 2012 |
| Suppression of Lipopolysaccharide‐stimulated Cytokine/Chemokine Production in Skin Cells by Sandalwood Oils and Purified α‐santalol and β‐santalol M Sharma, C Levenson, RH Bell, SA Anderson, JB Hudson, CC Collins, ... Phytotherapy research 28 (6), 925-932, 2014 | 49 | 2014 |
| HIT'nDRIVE: patient-specific multidriver gene prioritization for precision oncology R Shrestha, E Hodzic, T Sauerwald, P Dao, K Wang, J Yeung, ... Genome research 27 (9), 1573-1588, 2017 | 46 | 2017 |
| Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies W Jäger, H Xue, T Hayashi, C Janssen, S Awrey, AW Wyatt, S Anderson, ... Oncotarget 6 (25), 21522, 2015 | 46 | 2015 |
| Differences in MEK inhibitor efficacy in molecularly characterized low-grade serous ovarian cancer cell lines ML Fernández, GE DiMattia, A Dawson, S Bamford, S Anderson, ... American journal of cancer research 6 (10), 2235, 2016 | 45 | 2016 |
| Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target ML Fernandez, A Dawson, J Hoenisch, H Kim, S Bamford, C Salamanca, ... Cancer cell international 19, 1-17, 2019 | 36 | 2019 |
| Hiding in plain view: genetic profiling reveals decades old cross contamination of bladder cancer cell line KU7 with HeLa W Jäger, Y Horiguchi, J Shah, T Hayashi, S Awrey, KM Gust, ... The Journal of urology 190 (4), 1404-1409, 2013 | 36 | 2013 |
| Well-differentiated papillary mesothelioma of the peritoneum is genetically distinct from malignant mesothelioma R Shrestha, N Nabavi, S Volik, S Anderson, A Haegert, B McConeghy, ... Cancers 12 (6), 1568, 2020 | 25 | 2020 |
| Multiomics characterization of low-grade serous ovarian carcinoma identifies potential biomarkers of MEK inhibitor sensitivity and therapeutic vulnerability R Shrestha, M Llaurado Fernandez, A Dawson, J Hoenisch, S Volik, ... Cancer Research 81 (7), 1681-1694, 2021 | 23 | 2021 |
| A higher concentration of dialysate magnesium to reduce the frequency of muscle cramps: a narrative review A Varghese, E Lacson Jr, JM Sontrop, RR Acedillo, AA Al-Jaishi, ... Canadian Journal of Kidney Health and Disease 7, 2054358120964078, 2020 | 13 | 2020 |
